{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:55:29Z","timestamp":1791107729573,"version":"4.1.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.cgh.2010.08.026","type":"journal-article","created":{"date-parts":[[2010,9,25]],"date-time":"2010-09-25T04:43:58Z","timestamp":1285389838000},"page":"1017-1029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver"],"prefix":"10.1016","volume":"8","author":[{"given":"Ira M.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino","family":"Dal Maso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2010.08.026_bib1","unstructured":"OPTN. U.S. liver transplants performed: January 1, 1988\u2013April 30, 2008. Available at: http:\/\/www.optn.org\/. Accessed July 30, 2009."},{"key":"10.1016\/j.cgh.2010.08.026_bib2","first-page":"2060","article-title":"Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status","volume":"98","author":"Di Bisceglie","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.08.026_bib3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2007.03498.x","article-title":"Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis","volume":"26","author":"Snowberger","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2010.08.026_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2010.08.026_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/gut.2006.113217","article-title":"Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study","volume":"56","author":"Neal","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2010.08.026_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jhep.2007.04.006","article-title":"Outcome of hepatitis C infection: bleak or benign?","volume":"47","author":"Ryder","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.23020","article-title":"Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus","volume":"50","author":"Berenguer","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jhep.2008.04.012","article-title":"Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France","volume":"49","author":"Deuffic-Burban","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jhep.2007.02.010","article-title":"The natural history of hepatitis C with severe hepatic fibrosis","volume":"47","author":"Lawson","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhep.2006.10.017","article-title":"Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation","volume":"46","author":"Picciotto","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jhep.2006.08.020","article-title":"Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study","volume":"46","author":"Iacobellis","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib12","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.20659","article-title":"Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment","volume":"41","author":"Spiegel","year":"2005","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2010.08.026_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1478-3231.2008.01945.x","article-title":"What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?","volume":"29","author":"Alberti","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2010.08.026_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.dld.2006.06.008","article-title":"Extrahepatic manifestations of hepatitis C virus infection: a general overview and guidelines for a clinical approach","volume":"39","author":"Zignego","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2010.08.026_bib15","series-title":"Hepatology: a clinical textbook","first-page":"258","article-title":"Extrahepatic manifestations of chronic HCV","author":"Puchner","year":"2009"},{"key":"10.1016\/j.cgh.2010.08.026_bib16","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.166.19.2101","article-title":"Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia","volume":"166","author":"Saadoun","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2010.08.026_bib17","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2010.08.026_bib18","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/art.21270","article-title":"Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy","volume":"52","author":"Saadoun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2010.08.026_bib19","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/rheumatology\/kem132","article-title":"Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation","volume":"46","author":"Saadoun","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MNH.0b013e3282f8afe2","article-title":"Cryoglobulinemia and renal disease","volume":"17","author":"Alpers","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cgh.2010.08.026_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2003.11.020","article-title":"Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN","volume":"43","author":"Alric","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2010.08.026_bib22","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/art.10699","article-title":"Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"46","author":"Cacoub","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2010.08.026_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cgh.2010.08.026_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1432-2277.2002.tb00090.x","article-title":"Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis","volume":"15","author":"Duvoux","year":"2002","journal-title":"Transpl Int"},{"key":"10.1016\/j.cgh.2010.08.026_bib25","first-page":"6518","article-title":"Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients","volume":"13","author":"Stefanova-Petrova","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.08.026_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.bor.0000198002.42826.c2","article-title":"Cryoglobulinemic vasculitis","volume":"18","author":"Ferri","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib27","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial","volume":"81","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2010.08.026_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2010.08.026_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/BOR.0b013e3282f1330c","article-title":"Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis","volume":"20","author":"Saadoun","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib30","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2010.08.026_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.23305","article-title":"Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response","volume":"58","author":"Landau","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2010.08.026_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.2006.065565","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where do we stand?","volume":"67","author":"Cacoub","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2010.08.026_bib33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00415-009-5072-z","article-title":"Rituximab in cryoglobulinemic peripheral neuropathy","volume":"256","author":"Cavallo","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.cgh.2010.08.026_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12016-007-8019-0","article-title":"Rituximab as a therapeutic tool in severe mixed cryoglobulinemia","volume":"34","author":"Roccatello","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cgh.2010.08.026_bib35","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2007.081653","article-title":"Rituximab combined with peg-interferon-ribavirin in refractory HCV-associated cryoglobulinemia vasculitis","volume":"67","author":"Saadoun","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2010.08.026_bib36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus peg-interferon \u03b1\/ribavirin compared to peg-interferon \u03b1\/ribavirin in hepatitis C related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2010.08.026_bib37","first-page":"S39","article-title":"HCV infection: pathogenesis, clinical manifestations and therapy","volume":"26","author":"Antonelli","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 109","key":"10.1016\/j.cgh.2010.08.026_bib38","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"73","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.cgh.2010.08.026_bib39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2215\/CJN.00470107","article-title":"Hepatitis C virus infection and the prevalence of renal insufficiency","volume":"2","author":"Dalrymple","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cgh.2010.08.026_bib40","first-page":"813","article-title":"Therapy of hepatitis C virus-associated glomerulonephritis: current approaches","volume":"21","author":"Fabrizi","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/j.cgh.2010.08.026_bib41","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.08.026_bib42","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cgh.2010.08.026_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2010.08.026_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2010.08.026_bib45","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","article-title":"Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus","volume":"297","author":"Giordano","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2010.08.026_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2010.08.026_bib47","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2036.2005.02395.x","article-title":"Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection","volume":"21","author":"Gisbert","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2010.08.026_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.23462","article-title":"Hepatitis C virus infection and non-Hodgkin lymphoma: interesting association or causal relationship?","volume":"122","author":"Anderson","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cgh.2010.08.026_bib49","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood.V93.5.1778","article-title":"Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center","volume":"93","author":"Germanidis","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2010.08.026_bib50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ajh.1101","article-title":"Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France","volume":"67","author":"Hausfater","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cgh.2010.08.026_bib51","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V91.7.2433","article-title":"Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas","volume":"91","author":"Ivanovski","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2010.08.026_bib52","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.174.10.6532","article-title":"Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis","volume":"174","author":"Carbonari","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cgh.2010.08.026_bib53","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.1995.tb05582.x","article-title":"Clonal B-cell expansions in peripheral blood of HCV-infected patients","volume":"90","author":"Franzin","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cgh.2010.08.026_bib54","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.160.7.3594","article-title":"Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia","volume":"160","author":"Sansonno","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.cgh.2010.08.026_bib55","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","article-title":"Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes","volume":"101","author":"Machida","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cgh.2010.08.026_bib56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jmv.21388","article-title":"Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C","volume":"81","author":"Inokuchi","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.cgh.2010.08.026_bib57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2007.085910","article-title":"The BLyS\/BAFF receptor-ligand system in HCV induced B-cell clonal disorders","volume":"68","author":"Landau","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2010.08.026_bib58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.autrev.2008.05.005","article-title":"Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?","volume":"8","author":"De Vita","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cgh.2010.08.026_bib59","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/JVI.77.3.2134-2146.2003","article-title":"Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection","volume":"77","author":"Sung","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.cgh.2010.08.026_bib60","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.autrev.2007.03.010","article-title":"The pathophysiology of HCV induced B-cell clonal disorders","volume":"6","author":"Landau","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cgh.2010.08.026_bib61","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cgh.2010.08.026_bib62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0140-6736(92)91645-O","article-title":"Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease","volume":"339","author":"Haddad","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2010.08.026_bib63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2010.08.026_bib64","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.61.6.482","article-title":"Sjogren's syndrome criteria","volume":"61","author":"Manthorpe","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2010.08.026_bib65","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.53.10.637","article-title":"The European Community Study Group on diagnostic criteria for Sjogren's syndrome: sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome","volume":"53","author":"Vitali","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2010.08.026_bib66","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/art.1780390714","article-title":"Sicca syndrome associated with hepatitis C virus infection","volume":"39","author":"Jorgensen","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2010.08.026_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200101000-00001","article-title":"Hepatitis C virus infection mimicking primary Sjogren syndrome: a clinical and immunologic description of 35 cases","volume":"80","author":"Ramos-Casals","year":"2001","journal-title":"Medicine"},{"key":"10.1016\/j.cgh.2010.08.026_bib68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2796.1999.00414.x","article-title":"Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients","volume":"245","author":"Verbaan","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.cgh.2010.08.026_bib69","first-page":"2245","article-title":"Prevalence and characteristics of Sjogren's syndrome or sicca syndrome in chronic hepatitis C virus infection: a prospective study","volume":"28","author":"Loustaud-Ratti","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib70","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C: MULTIVIRC Group\u2014multidepartment virus C","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2010.08.026_bib71","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients: the GERMIVIC\u2014Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.cgh.2010.08.026_bib72","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00042737-199908000-00004","article-title":"Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection","volume":"11","author":"Goh","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib73","first-page":"613","article-title":"High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C","volume":"21","author":"Clifford","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib74","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0168-8278(02)00067-3","article-title":"Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C","volume":"36","author":"Cacoub","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1601-0825.2007.01436.x","article-title":"Oral diseases associated with hepatitis C virus infection: part 1\u2014sialadenitis and salivary glands lymphoma","volume":"14","author":"Carrozzo","year":"2008","journal-title":"Oral Dis"},{"key":"10.1016\/j.cgh.2010.08.026_bib76","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3899\/jrheum.081308","article-title":"Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? the ESPOIR cohort study","volume":"36","author":"Guennoc","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib77","first-page":"455","article-title":"Prevalence of rheumatoid arthritis and hepatitis C in those age 60 and older in a US population based study","volume":"30","author":"Hsu","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib78","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/ard.61.7.635","article-title":"Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis","volume":"61","author":"Maillefert","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2010.08.026_bib79","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.semarthrit.2003.12.006","article-title":"The case for hepatitis C arthritis","volume":"33","author":"Rosner","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cgh.2010.08.026_bib80","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00063030-200115090-00002","article-title":"Management of hepatitis C virus-related arthritis","volume":"15","author":"Zuckerman","year":"2001","journal-title":"BioDrugs"},{"key":"10.1016\/j.cgh.2010.08.026_bib81","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/rheumatology\/34.7.691","article-title":"A case of hepatitis C virus (HCV)-associated arthritis: quantitative analysis of HCV RNA of the synovial fluid and the serum","volume":"34","author":"Ueno","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib82","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-006-9510-9","article-title":"Cryoglobulinemia related to hepatitis C virus infection","volume":"52","author":"Dore","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.08.026_bib83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/14656566.6.1.27","article-title":"Management of hepatitis C virus-related arthritis","volume":"6","author":"Palazzi","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cgh.2010.08.026_bib84","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jbspin.2006.05.005","article-title":"Rheumatologic manifestations of chronic hepatitis C infection","volume":"73","author":"Lormeau","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cgh.2010.08.026_bib85","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10067-007-0729-4","article-title":"Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia","volume":"27","author":"Liu","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib86","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ard.2005.038042","article-title":"Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome","volume":"65","author":"Sene","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2010.08.026_bib87","first-page":"2139","article-title":"Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia: Multivirc Group","volume":"24","author":"Cacoub","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib88","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0168-8278(99)80337-7","article-title":"Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia","volume":"31","author":"Cacoub","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib89","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0198-8859(02)00423-8","article-title":"Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia","volume":"63","author":"De Rosa","year":"2002","journal-title":"Hum Immunol"},{"key":"10.1016\/j.cgh.2010.08.026_bib90","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2362.2003.01110.x","article-title":"Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome","volume":"33","author":"Zachou","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cgh.2010.08.026_bib91","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-122-3-199502010-00002","article-title":"Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes","volume":"122","author":"Pawlotsky","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.08.026_bib92","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","article-title":"Thyroid disorders in chronic hepatitis C","volume":"117","author":"Antonelli","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2010.08.026_bib93","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.genhosppsych.2005.06.006","article-title":"Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors","volume":"27","author":"Golden","year":"2005","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.cgh.2010.08.026_bib94","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jhep.2005.11.046","article-title":"Depression, anemia and health-related quality of life in chronic hepatitis C","volume":"44","author":"Dan","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib95","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gut.2006.100081","article-title":"Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?","volume":"55","author":"Forton","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2010.08.026_bib96","first-page":"484","article-title":"Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests","volume":"32","author":"Casato","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib97","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/gut.2005.080267","article-title":"Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment","volume":"55","author":"Weissenborn","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2010.08.026_bib98","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v66n0106","article-title":"Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction","volume":"66","author":"Raison","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.cgh.2010.08.026_bib99","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","article-title":"Neuropsychiatric adverse effects of interferon-alpha: recognition and management","volume":"19","author":"Raison","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.cgh.2010.08.026_bib100","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cgh.2008.02.034","article-title":"Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection","volume":"6","author":"Hanouneh","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib101","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.cgh.2008.03.024","article-title":"Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment","volume":"6","author":"Harrison","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib102","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.08.026_bib103","article-title":"Metabolic syndrome is a strong predictor of treatment failure in patients with chronic hepatitis C (abstract M1808)","author":"Hanouneh","year":"2007","journal-title":"Digestive Disease Week, Washington, DC"},{"key":"10.1016\/j.cgh.2010.08.026_bib104","article-title":"Metabolic syndrome in veterans with chronic HCV infection correlates with NAFLD activity score (abstract S1915)","author":"Pandya","year":"2006","journal-title":"Digestive Disease Week, Los Angeles, CA"},{"key":"10.1016\/j.cgh.2010.08.026_bib105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.mcg.0000190774.91875.d2","article-title":"Liver disease in patients with diabetes mellitus","volume":"40","author":"Harrison","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2010.08.026_bib106","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2036.2005.02598.x","article-title":"Review article: an unexpected virus-host interaction-the hepatitis C virus-diabetes link","volume":"22","author":"Ratziu","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2010.08.026_bib107","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.diabres.2006.07.008","article-title":"Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"75","author":"Shaheen","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cgh.2010.08.026_bib108","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwm061","article-title":"Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study","volume":"166","author":"Wang","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cgh.2010.08.026_bib109","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1432-2277.2008.00804.x","article-title":"New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies","volume":"22","author":"Chen","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.cgh.2010.08.026_bib110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/039139880803100801","article-title":"Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: a meta-analysis","volume":"31","author":"Fabrizi","year":"2008","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.cgh.2010.08.026_bib111","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0168-8278(01)00143-X","article-title":"Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C","volume":"35","author":"Petit","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib112","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1111\/j.1572-0241.2006.00835.x","article-title":"Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients","volume":"101","author":"Taura","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.08.026_bib113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00024382-200202000-00001","article-title":"Suppressors of cytokine signaling (SOCS): inhibitors of the JAK\/STAT pathway","volume":"17","author":"Cooney","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.cgh.2010.08.026_bib114","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cytogfr.2006.09.008","article-title":"Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions","volume":"17","author":"Rico-Bautista","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cgh.2010.08.026_bib115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/gut.2005.069674","article-title":"Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1","volume":"55","author":"Walsh","year":"2006","journal-title":"Gut"},{"issue":"Suppl 3","key":"10.1016\/j.cgh.2010.08.026_bib116","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2362.32.s3.4.x","article-title":"Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes","volume":"32","author":"Greenberg","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cgh.2010.08.026_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/qjmed\/hci001","article-title":"TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad","volume":"98","author":"Knobler","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.cgh.2010.08.026_bib118","doi-asserted-by":"crossref","first-page":"29911","DOI":"10.1074\/jbc.272.47.29911","article-title":"A molecular basis for insulin resistance: elevated serine\/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation","volume":"272","author":"Paz","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cgh.2010.08.026_bib119","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2003.08.007","article-title":"Hepatitis C virus infection and liver steatosis","volume":"60","author":"Ramalho","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.cgh.2010.08.026_bib120","series-title":"Nutrition and health","first-page":"291","article-title":"Adipokines in non-alcoholic fatty liver diseases","author":"Baranova","year":"2006"},{"key":"10.1016\/j.cgh.2010.08.026_bib121","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.22269","article-title":"Hepatitis C virus infection: molecular pathways to metabolic syndrome","volume":"47","author":"Sheikh","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib122","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.ijo.0802625","article-title":"Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients","volume":"28","author":"Bajaj","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.cgh.2010.08.026_bib123","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1365-2036.2006.03114.x","article-title":"Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin\/tumour necrosis factor-alpha in chronic hepatitis C patients","volume":"24","author":"Durante-Mangoni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2010.08.026_bib124","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/j.1572-0241.2006.00848.x","article-title":"The evolving role of leptin and adiponectin in chronic liver diseases","volume":"101","author":"Tsochatzis","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.08.026_bib125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jhep.2007.07.026","article-title":"Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3","volume":"48","author":"Poustchi","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib126","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"Romero-G\u00f3mez","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.08.026_bib127","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/hep.21125","article-title":"Correlation between insulin resistance and hepatitis C viral load","volume":"43","author":"Harrison","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib128","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1572-0241.2005.41403.x","article-title":"Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy","volume":"100","author":"D'Souza","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.08.026_bib129","first-page":"585","article-title":"Does a lower insulin resistance affect antiviral therapy response in patients suffering from HCV related chronic hepatitis?","volume":"55","author":"Tarantino","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2010.08.026_bib130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jhep.2007.11.022","article-title":"Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C","volume":"48","author":"Romero-Gomez","year":"2008","journal-title":"J Hepatol"},{"issue":"Suppl","key":"10.1016\/j.cgh.2010.08.026_bib131","first-page":"433A","article-title":"Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial","volume":"48","author":"Delgado-Borrego","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib132","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.22703","article-title":"Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C","volume":"49","author":"Arase","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib133","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1572-0241.2006.01038.x","article-title":"Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2","volume":"102","author":"Kawaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.08.026_bib134","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.2337\/dc06-0456","article-title":"Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection","volume":"29","author":"Simo","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cgh.2010.08.026_bib135","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1111\/j.1572-0241.2008.02002.x","article-title":"Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study","volume":"103","author":"Giordanino","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.08.026_bib136","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/hep.23206","article-title":"Treatment of insulin-resistance with metformin in na\u00efve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin","volume":"50","author":"Romero-Gomez","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib137","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2006.10.009","article-title":"Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis","volume":"46","author":"Bonkovsky","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib138","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.3748\/wjg.v11.i47.7494","article-title":"Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan","volume":"11","author":"Kang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.08.026_bib139","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.510290124","article-title":"Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy: the Consensus Interferon Study Group","volume":"29","author":"Bonkovsky","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib140","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.21565","article-title":"The effects of HCV infection and management on health-related quality of life","volume":"45","author":"Younossi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib141","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2036.2010.04235.x","article-title":"Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C","volume":"31","author":"Snow","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2010.08.026_bib142","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10620-007-9896-z","article-title":"Cognitive dysfunction in chronic hepatitis C: a review","volume":"53","author":"Perry","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.08.026_bib143","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jhep.2005.04.006","article-title":"Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial","volume":"43","author":"Fontana","year":"2005","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2010.08.026_bib144","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2893.2009.01188.x","article-title":"Investigating health-related quality of life, mood and neuropsychological test performance in a homogeneous cohort of Irish female hepatitis C patients","volume":"17","author":"Lowry","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cgh.2010.08.026_bib145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1468-1293.2007.00505.x","article-title":"Improved cognitive function as a consequence of hepatitis C virus treatment","volume":"8","author":"Thein","year":"2007","journal-title":"HIV Med"},{"key":"10.1016\/j.cgh.2010.08.026_bib146","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2893.2002.00364.x","article-title":"Fatigue in patients with chronic hepatitis C","volume":"9","author":"Poynard","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cgh.2010.08.026_bib147","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1365-2036.2006.02934.x","article-title":"Determinants of quality of life in chronic liver patients","volume":"23","author":"Gutteling","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2010.08.026_bib148","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s10620-006-9708-x","article-title":"Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection","volume":"52","author":"Kallman","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.08.026_bib149","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0168-8278(00)00026-X","article-title":"The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity","volume":"34","author":"McHutchison","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.08.026_bib150","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/archinte.161.18.2231","article-title":"Costs of hepatitis C","volume":"161","author":"Leigh","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2010.08.026_bib151","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.08.026_bib152","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.20941","article-title":"Trends in health care resource use for hepatitis C virus infection in the United States","volume":"42","author":"Grant","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.08.026_bib153","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2105\/AJPH.90.10.1562","article-title":"Estimating future hepatitis C morbidity, mortality, and costs in the United States","volume":"90","author":"Wong","year":"2000","journal-title":"Am J Public Health"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2010.08.026_bib154","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/135965350801301S05","article-title":"Future directions in therapy for chronic hepatitis C","volume":"13","author":"Jensen","year":"2008","journal-title":"Antivir Ther"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356510008955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356510008955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:06:13Z","timestamp":1761541573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356510008955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":154,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1542356510008955"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2010.08.026","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2010.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}